All probiotics are not the same in protecting premature infants from common, life-threatening illness

Disease is second most common cause of death among premies

2013-10-17

(Press-News.org) Treating premature infants with probiotics, the dietary supplements containing live bacteria that many adults take to help maintain their natural intestinal balance, may be effective for preventing a common and life-threatening bowel disease among premature infants, researchers at UC Davis Children's Hospital have found.

The study, "A comparison of two probiotic strains of bifidobacteria in premature infants," recently was published online in the Journal of Pediatrics. The bowel disease, necrotizing enterocolitis (NEC), is the second most common cause of death among premature infants, said Mark Underwood, lead study author, neonatologist and professor in the Department of Pediatrics at UC Davis Children's Hospital. It affects 3 to 10 percent of premature infants; about 25 percent of those with the severe form of this NEC succumb to the infection.

Underwood and his collaborators evaluated the effectiveness and safety of two types of probiotics of known purity and composition in a clinical trial that included nine breastmilk- and 12 formula-fed premature infants in the Neonatal Intensive Care Unit (NICU) at UC Davis Children's Hospital.

The products tested in the study were two genetically different strains of bifidobacteria, normal inhabitants of the gastroentestinal tract that inhibit the growth of harmful pathogens and bacteria, Bifidobacterium longum subspecies infantis (B. infantis); and Bifidobacterium animalis lactis (B. lactis).

Laboratory analysis of the bacterial contents of fecal samples from the infants, B. infantis was more effective at colonizing bifidobacteria, the healthy bacteria, in the newborns' gastrointestinal tracts than was B. lactis. The highest fecal levels of bifidobacteria were found in the infants who were breastmilk-fed and received the B. infantis probiotic, Underwood said.

No side effects were identified from administration of the two probiotic strains, Underwood said. One of the breast milk-fed infants treated with B. lactis developed NEC early in the trial, Underwood said, "indicating that B. lactis may not be as effective as B. infantis in protecting against NEC, though the study was not designed to answer that question."

Because earlier research conducted in Europe, Japan, and Australia has demonstrated the potential benefits of probiotic therapy in preventing NEC, many NICUs in the United States treat premature infants with the supplements, said Underwood. Probiotic therapy is not, however, the standard of care for premature infants in the United States. The American Academy of Pediatrics has not established a policy about using the products in newborns, and the U.S. Food and Drug Administration (FDA) currently regards probiotics as food supplements, not drugs.

The study was conducted in premature infants born between 24 to 33 weeks gestation and weighing less than 1,500 grams, or three pounds. It was conducted in two phases. In the first, the formula-fed infants were randomly assigned to receive either B. infantis or B. lactis in increasing doses over a five-week period. The second-phase evaluated the probiotics in breastmilk-fed premature infants. Each infant was treated with one strain for two weeks and after a one-week break, received the other strain for two weeks.

In both the formula-fed and breast milk-fed newborns, greater increases in fecal bifidobacteria occurred in the B. infantis groups than in the B. lactis groups.

"B. lactis colonization was not sustained in the infants," Underwood said.

"The highest total numbers and percentages of bifidobacteria were found after two weeks of B. infantis treatment in the breast milk-fed babies," said Underwood. "In addition, during the one week break in the phase of the study that involved the breast milk-fed infants, the relative abundance of bifidobacteria was significantly greater for those treated with B. infantis."

During periods of administration of B. infantis, the diversity of the beneficial microbes inhabiting the breast milk-fed babies' GI tract increased. In addition, the harmful bacteria known as γ-Proteobacteria decreased in the breast milk-fed babies who received B. infantis.

However, the formula-fed infants treated with B. infantis and B. lactis did not experience a decline in the γ-Proteobacteria, which typically increases at the onset of NEC and can cause serious tissue-damaging infections in the gastrointestinal system, lungs and other organs of the body.

The two strains of bifidobacteria used in the study were grown for UC Davis by a food-grade commercial facility, to insure that the infants in the study would receive probiotics of known purity and composition, Underwood said.

Specimens were obtained from the stool of the formula-fed infants at baseline, the beginning of the study, and then weekly for five weeks. In the breast milk-fed babies, the stool specimens were collected at baseline and following the first probiotic course, the one-week break and the second probiotic course.

Underwood is submitting an application for a new investigational drug to the FDA for a multi-centered second phase clinical trial to evaluate the safety and effectiveness of the B. infantis probiotic in preventing NEC in premature infants. If the application is approved and funded by the National Institues of Health, Underwood and his colleagues will conduct a larger trial involving more babies.

### The study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Development, the National Institute of Allergies and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases grant R01-HD059127 and by the National Center for Advancing Translational Sciences grant UL1 TR000002.

The study's other authors include Karen M. Kalanetra, Nicholas A. Bokulich, Zachery T. Lewis, Majid Mirmiran, Daniel J. Tancredi and David A. Mills, all of UC Davis.

UC Davis Children's Hospital is the Sacramento region's only nationally ranked, comprehensive hospital for children, serving infants, children, adolescents and young adults with primary, subspecialty and critical care. It includes the Central Valley's only pediatric emergency department and Level I pediatric trauma center, which offers the highest level of care for critically ill children. The 129-bed children's hospital includes the state-of-the-art 49-bed neonatal and 24-bed pediatric intensive care and pediatric cardiac intensive care units. With more than 120 physicians in 33 subspecialties, UC Davis Children's Hospital has more than 74,000 clinic and hospital visits and 13,000 emergency department visits each year. For more information, visit children.ucdavis.edu.

ELSE PRESS RELEASES FROM THIS DATE:

Physical activity in parks can been boosted by modest marketing

2013-10-17

Modest increases in marketing and outreach to local communities can increase the amount of physical activity that occurs in parks, providing a cost-effective way to potentially improve a community's health, according to a new RAND Corporation study. The project, which examined 50 parks across Los Angeles, found that simple interventions such as increased signage boosted physical activity by 7 to 12 percent over the study period in relation to parks that did not make changes. The findings are published online by the American Journal of Preventive Medicine. "The study ...

More US teens susceptible to HSV-1 infection, a growing cause of genital herpes

2013-10-17

[EMARGOED UNTIL THURSDAY, OCT. 17] A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. Published in The Journal of Infectious Diseases and available online, the findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years. Without these antibodies, today's teens may be more susceptible—when they become sexually active—to genital ...

Making the business case for cardiac rehab programs

2013-10-17

Montreal − You know the saying: an ounce of prevention is worth a pound of cure. When it comes to cardiac rehabilitation, a study presented today at the Canadian Cardiovascular Congress has the numbers to prove it. "We found that cardiac rehabilitation programs have a financial 'return on investment' of about seven per cent," says author Dr. Dennis Humen, a professor of medicine at Western University. "Not only is cardiac rehab the pillar of preventing a second cardiac event; it also makes good business sense." The study also revealed that, for patients, the 'return ...

A mother's high cholesterol before pregnancy can be passed on to her children

2013-10-17

Montreal − What leads to high cholesterol? Your genes and lifestyle factors may not explain it all. A study presented today at the Canadian Cardiovascular Congress has connected some of the risk for high cholesterol in adults to their mother's cholesterol levels before she even became pregnant. The key finding: if a mother had high LDL ("bad") cholesterol prior to a pregnancy, her children are almost five times as likely to also have high LDL cholesterol as adults. "Maternal health and exposures in the womb may be important in modifying cardiovascular disease ...

Unlocking a brighter future for locked-in syndrome

2013-10-17

Montreal − A team of researchers from Montreal has found that stroke patients living with Locked-In Syndrome (LIS) who cannot move, swallow or even breathe on their own, can regain a remarkable level of independence with technological help. The team's findings, to be presented at the Canadian Stroke Congress, stem from a 20-year study that followed the rehabilitation of 25 LIS patients, people who are aware and awake but cannot move or communicate verbally due to complete paralysis of nearly all voluntary muscles. "These patients can achieve a remarkable level ...

Eye contact builds bedside trust

2013-10-16

CHICAGO --- Doctors who make a lot of eye contact are viewed as more likable and empathetic by patients, according to a new Northwestern Medicine® study. Patients also gave doctors higher empathy scores when their total visit length was longer and when doctors engaged in a few "social touches" such as a handshake or pat on the back. However, more than three social touches in one visit decreased empathy scores. The researchers said it's possible that too many social touches from a doctor may seem forced and not genuine to a patient. The study, published in the Journal ...

UCSB researcher reveals the brain connections underlying accurate introspection

2013-10-16

(Santa Barbara, Calif.) –– The human mind is not only capable of cognition and registering experiences but also of being introspectively aware of these processes. Until now, scientists have not known if such introspection was a single skill or dependent on the object of reflection. Also unclear was whether the brain housed a single system for reflecting on experience or required multiple systems to support different types of introspection. A new study by UC Santa Barbara graduate student Benjamin Baird and colleagues suggest that the ability to accurately reflect on perceptual ...

New blood test could help millions of patients with gastrointestinal disorders

2013-10-16

LOS ANGELES (Oct. 15, 2013) – For the first time, a simple blood test may be the best way to determine if a patient is suffering from Irritable Bowel Syndrome (IBS), or another serious condition such as Inflammatory Bowel Disease (IBD,) according to Cedars-Sinai physician researcher Mark Pimentel, MD, lead author of a multicenter clinical trial. Researchers conclusively identified a test for antibodies that form against a particular protein, vinculin, found in the guts of patients, many of whom suffered acute gastroenteritis at some point. "This is a major breakthrough. ...

Researchers discover and treat toxic effects of ALS mutation in neurons made from patients' skin cells

2013-10-16

Researchers have discovered how the most common genetic abnormality in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) kills neurons and have successfully developed a therapeutic strategy to block this neurodegeneration in neurons made from the skin cells of ALS patients. The findings, which are published online in the October 16th issue of the Cell Press journal Neuron, have important implications for treating patients with these debilitating, currently incurable neurodegenerative diseases. The most common genetic mutation in ALS and FTD is an abnormal ...

Rare gene mutation sheds light on protein's role in brain development

2013-10-16

DURHAM, N.C. – Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments. An international team of scientists, led by genetic researchers at Duke Medicine, has solved the case by identifying a recessive gene mutation that reduces the abundance of a certain protein that previously had not been known to affect brain development. The gene mutation causes a defect in the body's synthesis of a nutrient ...

All probiotics are not the same in protecting premature infants from common, life-threatening illness

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: